Close Menu

NEW YORK — The US Food and Drug Administration has granted separate Emergency Use Authorizations for SARS-CoV-2 antibody tests developed by Siemens Healthineers and Advaite.

Separately, Siemens said on Tuesday that it has received CE marking for the use of its Clinitest Rapid COVID-19 Antigen Test with an additional specimen type.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.